GlobeNewswire Inc | Feb 11, 2021 04:17PM EST

February 11, 2021

CARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market close onThursday, February 25, 2021. Management will hold a conference call to review the company's financial performance starting at4:30 p.m. ETon the same day. The conference call will be concurrently webcast.

The link to the webcast will be available on theGenMark Diagnostics, Inc.website atwww.genmarkdx.comunder the investor relations section and will be archived for future reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number 6957136 approximately five minutes prior to the start time.

ABOUTGENMARK DIAGNOSTICSGenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor detection technology, GenMark's eSensor XT-8 and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMarks ePlex: The True Sample-to-Answer Solution is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.

Investor Relations ContactLeigh Salvo(415) 937-5404ir@genmarkdx.com